Trimethaphan: Clinical Trials

9 trials of Trimethaphan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 active not recruiting, 1 terminated, 1 withdrawn. 7 Phase 1, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 17Completed 3, Active not recruiting 2, Terminated 1, Withdrawn 1
Not applicable2Completed 2

Follow Trimethaphan: new trials by email Literature Review of Trimethaphan trials Research Report on Trimethaphan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autonomic Blockade and Endogenous Glucose Production
Trimethaphan, Saline - Insulin Resistance
Phase 1WithdrawnVanderbilt University Medical Center2017-04-172021-06-08
Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic
Trimethaphan, Placebo - Multiple System Atrophy, Orthostatic Hypotension
Phase 1Active not recruitingVanderbilt University22016-04-012026-03-13
Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension
Trimethaphan, Nitroglycerin - Hypertension
Phase 1Active not recruitingVanderbilt University122015-04-012026-08-27
Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
Angiotensin (1-7), Trimethaphan, Phenylephrine - Hypertension, Hypertension, Essential
Phase 1TerminatedVanderbilt University242015-01-012024-01-09
Autonomic Nervous System and Nitric Oxide Interactions
Trimethaphan, Placebo - Endothelial Dysfunction
Phase 1CompletedVanderbilt University212010-06-012018-02-28
Pathophysiology of Cardiometabolic Risk Factors in African Americans
L-NMMA, Trimethaphan - Obesity, Hypertension
Phase 1CompletedVanderbilt University Medical Center342010-01-012017-01-18
The Autonomic Nervous System and the Metabolic Syndrome
Blocked, Intact - Obesity
Not applicableCompletedVanderbilt University562008-08-012016-08-05
The Autonomic Nervous System and Obesity
Trimethaphan, Pseudoephedrine - OBESITY, HYPERTENSION
Phase 1CompletedVanderbilt University1282003-04-012018-03-01
Nitric Oxide and the Autonomic Nervous System
L-NMMA, Trimethaphan - Hypertension, Pure Autonomic Failure
Not applicableCompletedVanderbilt University1122002-08-012013-06-04

Conditions studied

Hypertension (6)  ·  Obesity (3)  ·  Pure Autonomic Failure (2)  ·  Essential Hypertension (1)  ·  Hypotension, Orthostatic (1)  ·  Insulin Resistance (1)  ·  Multiple System Atrophy (1)  ·  Shy-Drager Syndrome (1)

Sponsors

Vanderbilt University (7)  ·  Vanderbilt University Medical Center (2)

Countries

United States (9)

Top investigators

Italo Biaggioni, M.D. (3)  ·  Italo Biaggioni, MD (3)  ·  Cyndya Shibao, MD (1)

Results publications

PMID 17116758, PMID 17130304, PMID 18426998, PMID 22469621, PMID 34729682, PMID 39090323

NIH funding

K23HL103976 (1)